Neurological Surgery Doctors in White Plains, NY Accepting Medicare

9 Neurological Surgery doctors found. Showing 1 - 9

Dr. Thomas Lansen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 244 Westchester Ave, Suite 310, White Plains, NY 10604 Phone: 914-948-6688    Fax: 914-686-5478

Dr. Avinash Lalith Mohan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Westchester Park Dr Fl 4, White Plains, NY 10604 Phone: 914-948-8448    Fax: 914-345-8122

Dr. Ezriel Kornel, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4 Westchester Park Dr Fl 4, White Plains, NY 10604 Phone: 914-948-8448    Fax: 914-686-5478

Dr. Kent Duffy, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 244 Westchester Ave, Suite 310, White Plains, NY 10604 Phone: 914-948-6688    Fax: 914-686-5478

Dr. Alain C J De Lotbiniere, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Westchester Park Dr, Ste 320, White Plains, NY 10604 Phone: 914-948-6688    Fax: 914-686-5478

Dr. John Abrahams, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Westchester Park Dr, Fl 4, White Plains, NY 10604 Phone: 914-948-6688    Fax: 914-686-5478

Adesh Tandon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Longview Ave, White Plains, NY 10601 Phone: 914-849-7593

Dr. Kamran Tabaddor, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 244 Westchester Ave, Suite 310, White Plains, NY 10604 Phone: 914-948-6688    Fax: 914-686-5478

Dr. Virany Huynh Hillard, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Westchester Park Dr, Fl 4, White Plains, NY 10604 Phone: 914-345-8111    Fax: 914-345-3122

News Archive

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma

Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.

Study elucidates pathophysiology of systemic lupus erythematosus

Osaka University researchers elucidated the pathophysiology of systemic lupus erythematosus, an autoimmune disorder that causes inflammation and tissue damage.

Researchers study specially bred mice to understand annual flu epidemics

As part of a national collaboration, Oregon Health & Science University researchers are studying specially bred mice that are more like humans than ever before when it comes to genetic variation. Through these mice, the researchers hope to better understand and treat an infectious disease that plagues us year in and year out: the flu.

USPTO allows claims to Rosetta Genomics' two microRNA related patent applications

Rosetta Genomics today announced that the United States Patent and Trademark Office has allowed claims in two patent applications.

Read more Medical News

› Verified 2 days ago